Smart immune cells take aim at Hard-to-Treat cancers
Disease control
Recruiting now
This study tests a new type of CAR T cell therapy for adults with advanced solid tumors, including colorectal, pancreatic, lung, ovarian, and mesothelioma cancers. The treatment uses the patient's own immune cells, modified to target cancer cells while sparing healthy ones. The s…
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated May 03, 2026 21:22 UTC